How do SSRIs primarily alleviate symptoms of depression?

How do SSRIs primarily alleviate symptoms of depression?

• A. By increasing serotonin absorption at the postsynaptic neuron
• B. By increasing serotonin release from the presynaptic neuron
• C. By enhancing the rate of serotonin synthesis in presynaptic neurons
• D. By prolonging the presence of serotonin in the synaptic space

Answer: (D)

SSRIs, or selective serotonin reuptake inhibitors, primarily alleviate symptoms of depression by prolonging the presence of serotonin in the synaptic space. They achieve this by blocking the reuptake of serotonin into the presynaptic neuron after it has been released into the synaptic cleft. This inhibition allows serotonin to remain in the synaptic cleft for a longer duration, which increases the likelihood of binding to postsynaptic receptors. Increasing the availability of serotonin at the synaptic cleft enhances neurotransmission, which is thought to contribute to the improvement of mood and reduction of depressive symptoms. By maintaining higher levels of serotonin in the synaptic space, SSRIs can effectively lead to better signaling between neurons that is essential for mood regulation. This mechanism of action distinguishes SSRIs from other potential options, such as increasing serotonin release or enhancing synthesis, which are not the primary actions of SSRIs. Instead, their efficacy is tied to the reuptake inhibition, providing a clear rationale for their role in treating depression.

SSRIs, or selective serotonin reuptake inhibitors, primarily alleviate symptoms of depression by prolonging the presence of serotonin in the synaptic space. They achieve this by blocking the reuptake of serotonin into the presynaptic neuron after it has been released into the synaptic cleft. This inhibition allows serotonin to remain in the synaptic cleft for a longer duration, which increases the likelihood of binding to postsynaptic receptors.

Increasing the availability of serotonin at the synaptic cleft enhances neurotransmission, which is thought to contribute to the improvement of mood and reduction of depressive symptoms. By maintaining higher levels of serotonin in the synaptic space, SSRIs can effectively lead to better signaling between neurons that is essential for mood regulation.

This mechanism of action distinguishes SSRIs from other potential options, such as increasing serotonin release or enhancing synthesis, which are not the primary actions of SSRIs. Instead, their efficacy is tied to the reuptake inhibition, providing a clear rationale for their role in treating depression.